The KanaVape trial: what's at stake?
Next Monday sees the trial in Marseille of KanaVape, the first CBD-based electronic cigarette marketed in France in 2014.
Revolutionary at the time, the product was accused of being presented as a drug. The French Ministry of Health pushed hard to prohibit all marketing of the product in France, and to prosecute the two founders of KanaVape, Antonin Cohen and Sébastien Béguerie.
Antonin and Sébastien are not exactly strangers. One is now at the helm of Harmony, the recently launched featured on the front page of Le Parisien, the other markets cannabinoid test kits and CBD products under the brand name Alpha-Cat and is the co-founder of UFCM and co-organizer of the UFCM-I-Care conference in Strasbourg on the use of cannabinoids in medicine.
Both know their stuff, and have paved the way for all CBD e-liquids marketed in France today. So what will come out of this trial, even though the French Ministry of Health asserted this week in Le Parisien that these products are legal? We can't really answer that, or predict the outcome. But it goes without saying that we'll be following it closely.
Deliberation is scheduled for early 2018.
-
Business3 weeks ago
Will CBD edibles be banned on May 15 in France? An update on the situation
-
Cannabis in Austria4 weeks ago
Austrian court deals first blow to proposed tobacco monopoly on hemp flowers
-
Cannabis in France3 weeks ago
Medical cannabis: 92% of the French in favor but 0 access
-
Business4 weeks ago
Germany: an experimental cannabis store near Düsseldorf?
-
Cannabis in Spain4 weeks ago
Spannabis Champions Cup 2026: Bilbao results
-
Business3 weeks ago
Bedrocan unveils Bedromed, a new range of standardized cannabinoid-based formulations
-
Cannabis in the U.S.4 weeks ago
DEA confirms that HHC is federally banned
-
Cannabis in Israel4 weeks ago
Israel turns the page on smoked medical cannabis


You must be logged in to post a comment Login